Delivery Order SPE2DB22D2108-SPE2DB25FU5KS
Award Date 8/11/25
Potential Completion Date 8/12/25
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $6,072.71 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Entresto is a combination medication used primarily for heart failure treatment, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg–26 mg tablets (60-count) on August 11, 2025, under a firm fixed-price contract with a ceiling value of $2,278.14. The order is set to be completed by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive, non-set-aside award issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count) valued at $3,510.76. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this pharmaceutical supply transaction, which will be fulfilled from...
- The Defense Logistics Agency awarded a $4,224.46 delivery order to AmerisourceBergen Drug Corp for Entresto 97 mg-103 mg tablets (60-count supply) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Entresto is a combination medication primarily used in the treatment of heart failure,...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.89 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Entresto 49 mg-51 mg tablets (60-count units). This firm fixed price delivery order, with an ultimate completion date of August 12, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and supports the agency's medical supply chain...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency awarded a delivery order valued at $2,989.52 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count package) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Entresto is a cardiovascular medication commonly used in the...
- The Defense Logistics Agency awarded a $68,784.07 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment under the company's broader pharmaceutical supply arrangements. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25K to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg–26 mg tablets (180-count units) on July 30, 2025, with completion targeted for July 31, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate headquarters location in Conshohocken, Pennsylvania. Entresto is a combination medication used primarily for heart failure...